1Green KL,Brown C,Roeder GE,et al.A cancer ceil-specific inducer of apoptosis[J].Hum Gene Ther,2007,18(6):547-561.
2Wu MH,Chan JY, Liu PY, et al.Human papillomavirus E2 protein associates with nuclear receptors to timulate nuclear receptor and E2 dependent transcripitioanl activations in human cervical carcinoma cells[J].Int J Biochem Cell Biol, 2008,39(2):413-425.
3Homer SM,Dimaio D.The DNA binding domain of a papollomavirus E2 protein prograrns a chimeric nuclease to cleave integrated human papillomavirus DNA in Hela cervical carcinoma cells[J].J Virol,2008,8( 12):6254--6264.
4Kitchener HC,Walker PG,Nelson L,et aI.HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia[J].BJOG,2008,115(8): 1001- 1037.
5Petry KU,Breugelmans JG,Benard S,et al.Cost of screening and treatment of cervical dyskaryosis in Germany [J].Eur J Gynaecol Oncol, 2008,29(4):345-349.
6Xi LF,Kiviat NB,Galloway DA,et al.Effect of cervical cytology status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3 [J].J Infect Dis,2008,198(3): 324-331.
7Dixon EP,King LM,Adams MD,et aHsolation of RNA from residual BD Sure Pathtrade mark liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the preTecttrade mark HPV-Proofer assay[J].J Virol Methods, 2008,28(6):322-326.
9Nishiwaki M,Yamamoto T, Tone S,et al. Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications[J].J Clin Microbiol,2008,46(4): 1161-1168.
10Weyn C,Boulenouar S,Mathys V, et al.Detection of human papillomavirus types 45 and 51 by type specific polymerase chain reaction[J].J Virol Methods, 146(2):405-408.
6Huang S,Afonina I,Miller BA,et al.Huamn papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women.Int J Cancer,1997,73:775-776.
7Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis.Br J Cancer,2003,88:63-73.
8McLachlin CM.Human Papillomavirus in cervical neroplasia.Role,risk factors and implications.Clin Lab Med,2000,20:257-270.
9Masumoto N,Fujii T,Ishikawa M,et al.Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women;study of 881 outpatients.Gynecol Oncol,2004,94:509-514.
10Stanczuk GA,Kay P,Sibanda E,et al.Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix.Acta Obstet Gynecol Scand,2003,82:762-766.
2Michael J,Matthew J,Singh M. IR microspectroscopy:potential applications in cervical cancer screening[J].Cancer Letters,2007,(1-2):1-11.
3Lai CH,Huang HJ,Hsueh S. Human papillomavirus genotype in cervical cancer:a population-based study[J].International Journal of Cancer,2007,(09):1999-2006.doi:10.1002/ijc.22538.
4Dai M,Bao YP,Li N. Human papillomavirus infection in Shanxi Province,Peoples′ Republic of China:a population-based study[J].British Journal of Cancer,2006,(01):96-101.
5Li LK,Dai M,Clifford GM. Human papillomavirus infection in Shenyang City,People′s Republic of China:a population based study[J].British Journal of Cancer,2006,(11):1593-1597.
